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ORIGINAL ARTICLE

Early Ischemic Stroke Presentation in
Pakistan
Ayeesha Kamran Kamal, Bhojo Asumal Khealani, Sajjad Ahmed Ansari,
Maria Afridi, Nadir Ali Syed

ABSTRACT: Introduction: There are no studies from Pakistan that describe stroke presentation rates or factors associated with early
or delayed presentation. This is important to know because current clinical protocols limit the use of recombinant tissue plasminogen
activator (rtPA), the only available therapy for acute ischemic stroke, to a three-hour window from symptom onset. Methods: All
patients aged 14 years or above with acute ischemic stroke of ≤ 48 hours duration were prospectively identified from the Aga Khan
University Stroke Data Bank over a 22-month period ending May 2001. Results: 269 ischemic stroke patients presented within 48 hours
of stroke onset. 55 out of 269 (21%) presented within first three hours and 110 out of 269 (41%) within first six hours. Unawareness of
treatment options (p <0.001) and inappropriate diagnosis and field triage (p=0.005) were associated with delayed presentation. Small
vessel occlusion or lacunar stroke in the TOAST (Trial of ORG 10172 in Acute Stroke Treatment) ischemic stroke subtype was
associated with delayed presentation (p=0.047) and cardioembolic stroke was associated with earlier presentation (p=0.048). Stroke
severity assessed with the National Institutes of Health Stroke Scale at a cut off score of ≥15 was not associated with earlier time to
presentation at three hours (p=0.114) but there was some tendency at six hours (p=0.097). Conclusions: The rate of early stroke
presentation in a Pakistani tertiary care facility is comparable to certain developed countries. To increase the proportion of patients who
can benefit from thrombolytic therapy, programs need to be instituted to increase public awareness of treatment options for stroke and
expedited referral by the primary care provider.
RÉSUMÉ: Consultation précoce dans l’accident vasculaire cérébral ischémique au Pakistan. Contexte : Il n’y a pas d’étude au Pakistan décrivant
les taux de consultation dans l’accident vasculaire cérébral (AVC) ou les facteurs associés à une consultation précoce ou tardive. Ce sont des
informations importantes à cause des limites actuelles des protocoles cliniques pour l’utilisation de l’activateur du plasminogène recombinant (rt-PA),
le seul traitement disponible pour l’AVC ischémique aigu. Ce traitement doit être administré en dedans de 3 heures du début des symptômes. Méthodes
: Tous les patients âgés de 14 ans et plus, présentant un AVC ischémique aigu de moins de 48 heures, ont été identifiés de façon prospective dans la
banque de données de l’AVC de l’Université Aga Khan sur une période de 22 mois se terminant en mai 2001. Résultats : Deux cent soixante-neuf
patients atteints d’un AVC ischémique ont consulté dans les 48 heures du début des symptômes. Cinquante-cinq d’entre eux (21%) ont consulté dans
les trois premières heures et 110 (41%) dans les six premières heures. La méconnaissance des options thérapeutiques (p < 0,001) et un diagnostic et un
triage inappropriés (p = 0,005) étaient associés au retard à consulter. Dans l’essai clinique TOAST (Trial of ORG 10172 in Acute Stroke Treatment) sur
les sous-types d‘AVC, une occlusion d’un vaisseau de petit calibre ou un AVC lacunaire était associé à une consultation tardive (p = 0,047) et l’AVC
cardioembolique était associé à une consultation plus précoce (p = 0,048). La sévérité de l’AVC évaluée au moyen du National Institutes of Health
Stroke Scale avec un point de coupe de 15 et plus n’était pas associée à une consultation plus précoce dans le groupe qui avait consulté en dedans de 3
heures (p = 0,114), mais on notait une tendance en ce sens dans le groupe qui avait consulté en dedans de 6 heures (p = 0,097). Conclusions : Le taux
de consultation précoce chez les patients présentant un AVC aigu dans les hôpitaux de soins tertiaires au Pakistan est comparable à celui de certains
pays industrialisés. Il faudra établir des programmes d’information pour que le public soit au courant des options thérapeutiques dans l’AVC et de
l’importance d’une référence rapide par le personnel médical de première ligne.

Can. J. Neurol. Sci. 2009; 36: 181-186
Recombinant tissue plasminogen activator (rtPA) is the only
available therapy for acute ischemic stroke. Current clinical
protocols limit its use to a three-hour window from symptom
onset. The role of thrombolytic therapy between 91 and 180
minutes after stroke onset remains highly controversial.
However, studies have shown that rtPA given within six hours of
stroke reduced death or dependency (i.e. more patients alive and
independent) at three to six months, and this was statistically
significant in favor of treatment.1-4 Late presentation continues to
be a primary cause of exclusion from thrombolytic therapy
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among stroke patients. The data for stroke presentation has not
been reported from Pakistan.
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Sample Selection

This study presents the results of the hospital based Aga Khan
University Stroke Data Bank evaluating stroke patients admitted
to a large tertiary care medical center. In this observational study,
we report the exceptionally large proportion of stroke patients
presenting to the Emergency Department of a tertiary-care
hospital in Karachi, Pakistan, within three hours of symptom
onset and consequentially, a substantial difference in the number
of patients eligible for thrombolytic therapy compared to
published data from other countries.5-15 (Table 1)

All acute stroke patients over the age of 14 years presenting
to the Emergency Department from August 1999 to May 2001
were eligible to be enrolled in the Aga Khan University Stroke
Data Bank. There were two patients who were <18 years-of-age,
one presented >36 hours and the other <3 hours post onset.
Patients with subarachnoid, subdural or epidural hemorrhage and
transient ischemic attack (TIA) were excluded from the Data
Bank. Any patient with an in-hospital stroke was also excluded.
Acute stroke was defined according to the WHO criteria as a
rapidly evolving focal or global neurological deficit with
symptoms leading to death or lasting >24 hours due to a vascular
etiology.16 Causes other than stroke were ruled out by brain
imaging and other diagnostic studies. The diagnosis of stroke
was verified by a neurologist, and a head CT scan was performed
in all cases.

MATERIALS AND METHODS

Study Design and Setting

This historical cohort was conducted from August 1999 to
May 2001 at the Neurology Department of the Aga Khan
University Hospital, Karachi, Pakistan. The Aga Khan
University Hospital is a major tertiary care health facility, which
caters to a large urban population of approximately 15 million.
Table 1: International stroke presentation rates
Study Setting

Population
Characteristics

Median
Prehospital
Delay &
Range/min

%
presenting
< 3 hours

%
presenting
< 6 hours

Rossnagel et al
Ann Emerg Med
2004;44: 476-483

Germany

Multicentre
Prospective
Cross-sectional

N=558
IC: Acute Stroke
with onset < 7
days

151
(5 - 9590)

N/A

N/A

Harraf et al
BMJ 2002; 325:17-21

UK & Dublin

N=739
IC: Acute Stroke

360
(108-1152)

37

50

Barber et al
Neurology 2001 Apr
24; 56(8):1015-20
Morris et al
Stroke 2000; 31:25852590

Calgary,
Canada

Multicentre
Prospective
Observational
Multicentre
Prospective

N/A

27

N/A

Genentech
Stroke
Presentation
Survey, USA

Multicentre
Prospective

156
(72-378)

56

75

Chang et al
Stroke 2004; 35:700704

Taiwan

Prospective

335
(112-860)

26

N/A

Casetta et al
Neuroepidemiology
1999;18:255-264

Italy

Prospective

N=1168
IC: Acute
Ischaemic Stroke
N=1207
IC: Acute Stroke
with onset <24
hours, age ! 18
years
N=196
IC: Acute Stroke
with onset < 48
hours
N=760
IC: Acute Stroke

210

41

Vemmos et al
Cerebrovascular
Diseases 2000;
10:133-141

Athens

Prospective

N=1042
IC: Acute Stroke

N/A

46

N/A

Derex et al Stroke
2002;33:153

France

Prospective

N=166
IC:
Acute Stroke

245

29

75

Streifler et al
Neuroepidemiology
1998;17:161-166

Israel

Prospective

N=216
IC:
Acute Stroke

N/A

18

54

Leopoldino et al Arq
Neuropsiquiatr. 2003
Jun; 61(2A):186-7

Brazil

Prospective

N=50 (59 for all)
IC: Acute
Ischaemic Stroke

1126 (for all
acute)

26 (28 for all
strokes)

30 (32 for
all stroke)

Srivastava et al
Neurol India
2001;49:272-6

India

Prospective

N=110
IC: Acute Stroke
with onset < 72
hours

460

25

49

IC=Inclusion Criteria
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Table 2: Characteristics of patients with ischemic stroke presenting within 48 hours. (n=269 unless stated otherwise)
Variables

Frequency (Percent)

<3 hours
Frequency (Percent)

P value

Mean(±Standard deviation);
Median

61 (±13.316) years; 62 years

!50
51-60
61-70

50 (18.6%)
81 (30.1%)
82 (30.5%)

11 (22.0%)
19 (23.5%)
15 (18.3%)

"71
Male
Female
Upper

56 (20.8%)
174 (64.7%)
95 (35.3%)
67 (25.9%)

10 (17.9%)
32 (18.4%)
23 (24.2%)
14 (20.9%)

Middle

163 (62.9%)

32 (19.6%)

Lower

29 (11.2%)

6 (20.7%)

Illiterate
Primary

32 (20.5%)
26 (16.7%)

4 (12.5%)
7 (26.9%)

Matric
Intermediate
Graduate
Postgraduate

26 (16.7%)
20 (12.8%)
42 (26.9%)
10 (6.4%)

5 (19.2%)
4 (20.0%)
5 (11.9%)
1 (10.0%)

Transport problem

19 (7.1%)

3 (15.8%)

0.773

Patient unawareness of treatment options

56 (20.8%)

2 (3.6%)

<0.001

Inappropriate diagnosis and field triage

57 (21.2%)

4 (7.0%)

0.005

Financial problem
Ischemic Stroke Subtype

5 (1.9%)
67 (24.9%)
120 (44.6%)

1 (20.0%)
15 (22.4%)
18 (15.0%)

1.000
0.649
0.047

21 (7.8%)
11 (4.1%)

8 (38.1%)
4 (36.4%)

0.048
0.244

50 (18.6%)

10 (20.0%)

0.931

216 (80.3%)
53 (19.7%)

40 (18.5%)
15 (28.3%)

0.114

Prior stroke
Prior transient ischemic attack (TIA)

56 (20.8%)
20 (7.4%)

13 (23.2%)
4 (20.0%)

0.564
1.000

Coronary artery disease
Myocardial infarction

73 (27.1%)
37 (13.8%)

17 (23.3%)
11 (29.7%)

0.481
0.132

Diabetes mellitus
Hypertension

106 (39.4%)
164 (61.0%)

17 (16.0%)
33 (20.1%)

0.148
0.869

Hyperlipidemia

52 (19.3%)

11 (20.0%)

0.888

Atrial fibrillation
Congestive heart failure

7 (2.6%)
10 (3.7%)

2 (28.6%)
4 (40.0%)

0.634
0.125

Rheumatic heart disease
Currently smoker
Former smoker

5 (1.9%)
34 (12.6%)
56 (20.8%)

2 (40.0%)
6 (17.6%)
13 (23.2%)

0.271
0.665
0.564

Age

Sex
Socio-economic Status
(n=259)

Education
(n=156)

NIHSS score

Volume 36, No. 2 – March 2009

Large Vessel Atherosclerosis
Small Vessel Occlusion or
Lacunar Stroke
Cardioembolic Stroke
Stroke of Other Determined
Cause
Stroke of Other
Undetermined Cause
!15 (mild-moderate)
> 15 (severe)

0.804

0.258
0.973

0.600
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Data Collection and Methods of Measurement

The time of stroke onset was defined as the time when
symptoms of stroke first occurred. If symptoms were first noted
on awakening, onset was defined by when last observed to be
normal.
Patients were worked up according to an established clinical
stroke pathway, and investigations included neuroimaging (CT
or MRI), electrocardiogram, transthoracic echocardiogram,
complete blood count, coagulation profile, serum electrolytes,
blood urea nitrogen, creatinine, urine detailed report, and carotid
Doppler ultrasonography. Selected patients underwent transesophageal echocardiogram with bubble contrast, 24 hours holter
monitoring and work up for hypercoagulable state. All patients
were evaluated by a consultant neurologist, and the data was
collected by neurology house staff on a standardized precoded
data entry form. The data was collected in real time during the
patient's hospital stay, and the patient's discharge was the end
point for the purpose of this study.

Statistical Analyses

The quantitative data is presented in mean with standard
deviation or median as appropriate. Univariate analysis was
carried out to assess factors influencing the outcome (delay in
presentation) using Chi square and student’s t test. Association of
categorical variables with outcome was performed with Pearson
χ2 or Fisher exact test as appropriate and association between
quantitative variables and outcome was performed with student’s
t test.
SPSS (Statistical Package for the Social Sciences) version
15.0 for Windows was used for all calculations.
RESULTS

During the 22 month period, there were 596 patients enrolled
in the AKU (Aga Khan University) Stroke Data Bank. Of these,
393 patients suffered from ischemic stroke and 126 were
diagnosed with a primary intracerebral hemorrhage. Twentyseven patients were con-sidered not to have suffered a stroke (22
TIA, two psychogenic symptoms and one metabolic
encephalopathy presenting as a stroke). An additional 50 patients
with subarachnoid hemorrhage were enrolled, but excluded from
analysis.
Our study focuses on the ischemic stroke group. Despite
excluding “late presenters” from geographically remote regions
and neighboring countries, 269 of the total 393 ischemic stroke
patients (68.4%) presented within the first 48 hours of stroke
onset. In this group, there were 174 (64.7%) men and 95 (35.3%)
women with a male to female ratio of 1.83. The mean age was 61
years (±13.32) with median of 62 years (Table 2). 55 out of 269
ischemic patients (20.4%) presented within 0-3 hours and 110
out of 269 (40.9%) within 0-6 hours (Table 3). The median time
to presentation after stroke onset was 7 hours (420 minutes) i.e.
51.4% patients presented within 0-7 hours.
The most common reasons that patients reported for delay in
presentation were unawareness of treatment options (p<0.001),
and inappropriate diagnosis and field triage (p=0.005) (Table 3).
There were no symptom recognition delays reported. In ischemic
stroke subtype according to the TOAST (Trial of ORG 10172 in
Acute Stroke Treatment) criteria17, small vessel occlusion or
184

lacunar stroke was associated with delayed presentation
(p=0.047) and cardioembolic stroke was associated with earlier
presentation (p=0.048) whereas there was no association with
large vessel atherosclerosis, stroke of other determined cause and
stroke of other undetermined cause. Stroke severity measured
with the National Institutes of Health Stroke Scale at a cut off
score of ≥15 was not associated with earlier time to presentation
at 3 hours (p=0.114) but there was some inclination at 6-hours
(p=0.097). There was also no association with age, sex, literacy,
socioeconomic status, transport problems, financial problems,
prior stroke, transient ischemic attack and other comorbidities
including diabetes mellitus, hypertension, dyslipidemia,
coronary artery disease, atrial fibrillation, congestive heart
failure and rheumatic heart disease.
DISCUSSION

Karachi, with a population of over 15 million, is the largest
city in Pakistan. Being a developing nation, with the increasing
problems of the developed world, it endures a double burden of
disease.18 Stroke is a common clinical problem in Pakistan,
accounting for 6.4% of all hospital admissions in two major
hospitals in Karachi.19 The single prevalence study on a single
ethnic community within Pakistan reports a prevalence rate of
4.8%20 which is alarmingly high. However, the results of this
study should be interpreted with caution as a non-validated
questionnaire was used. There are no community incidence data
available from Pakistan.
In a country where stroke rehabilitation centers are numbered
and the fallout of stroke is devastating, early aggressive tissue
salvage therapy is crucial. A substantial delay in the presentation
of acute stroke was expected. However, our study shows that
almost a quarter of the patients presented within the first three
hours of stroke onset and as many as 40% within six hours.
These percentages are comparable to internationally published
data5-15 from more developed nations. The hospital net is
nationwide and the university has a nursing program covering
Afghanistan. It is not uncommon for patients to be brought in

Table 3: Hours between stroke onset and hospital
presentation
Hours

Frequency (Percent)

<3

55 (20.4%)

20.4%

4-6

55 (20.4%)

40.9%

6-12

68 (25.3%)

66.2%

12-24

62 (23%)

89.2%

25-48

29 (10.8%)

100%

Total

Cumulative Percent

269 (100 %)
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from geographically remote regions and from neighboring
countries. Thus we excluded all “late presenters” from the
analysis. Despite these conditions, 269 out of 393 (68.4%)
presented within 0-48 hours.
Patient awareness of stroke symptoms was not associated
with early presentation to hospital as reported in several
studies.21-23 Attention to factors that go beyond symptom
awareness such as education regarding new stroke treatments
options and the limited time interval for effective therapy may
increase the proportion of patients arriving within the first hours
after stroke onset.12,24,25 These observations are also illustrated in
our study that unawareness of treatment options was associated
with significant delay to hospital presentation (p <0.001). The
longest phase of delay is reported to be the time from symptom
recognition to the decision to seek medical care.25 Awareness of
treatment options may play an important role in deciding to seek
medical care apart from other factors and, therefore, may become
a potent factor in reducing this longest phase of delay.
If physicians were contacted, the patients were often
inappropriately triaged leading to delays (p=0.005) as described
in the literature.15,25-27 This underscores the need to set
mechanisms in place at the general practitioners level to expedite
diagnosis and referral to the organized stroke centers.
Small vessel occlusion or lacunar stroke according to the
TOAST ischemic stroke subtype presented late (p=0.047)
whereas cardioembolic stroke presented early (p=0.048). Late
presentation in lacunar strokes might be attributed to milder
stroke symptoms and low threat perception by the patient.
Lacunar stroke was also the most common subtype of ischemic
stroke presentation (44.6%) (Table 2) as reported previously in
AKU Stroke Data Bank.19 However there was no association
found with large vessel atherosclerosis, stroke of other
determined cause and stroke of other undetermined cause.
Stroke severity assessed with the National Institutes of Health
Stroke Scale (NIHSS) was not associated with early admission to
hospital at 3 hours (p=0.114) but there was some tendency at 6
hours. (p=0.097) at a cut off score of NIHSS >15. Stroke severity
has been shown to be associated with early arrival in many13,21,2528 but not all studies29-31. All patients should seek immediate
medical attention irrespective of the severity of stroke as every
third stroke patient with mild to moderate symptoms may
deteriorate with increased risk of morbidity and mortality.32
Age, sex, literacy, socioeconomic status, prior stroke or
transient ischemic attack did not show any association with the
time interval of arrival, neither did the risk factors for stroke
including hypertension, diabetes mellitus, dyslipidemia and
smoking along with the other comorbidities including coronary
artery disease, atrial fibrillation, rheumatic heart disease and
congestive heart failure as reported in several studies.8,23,25,28,29,33
The socio-cultural profile of Pakistan differs from that of the
western world. Despite the furious pace of change and
modernization that has occurred in Pakistan over the last several
years, the traditional extended family still forms the basic unit of
society. This ensures that the elderly are constantly under
observation, which may enable rapid recognition of stroke onset
in this setting despite the lack of literacy.
Stroke recognition and reporting in this region is
unexpectedly early, facilitated by the extended family system.
Effective programs are needed to benefit patients from
Volume 36, No. 2 – March 2009

thrombolytic therapy including increasing public awareness of
treatment options for stroke, seeking immediate medical
attention despite mild to moderate symptoms and expediting
diagnosis and referral by the primary care giver.
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